These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 38224447)

  • 41. Enterohemorrhagic Escherichia coli trivalent recombinant vaccine containing EspA, intimin and Stx2 induces strong humoral immune response and confers protection in mice.
    Gu J; Liu Y; Yu S; Wang H; Wang Q; Yi Y; Zhu F; Yu XJ; Zou Q; Mao X
    Microbes Infect; 2009 Sep; 11(10-11):835-41. PubMed ID: 19427397
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Enterohemorrhagic
    Detzner J; Pohlentz G; Müthing J
    Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35805890
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Neutralizing activity of polyvalent Gb3, Gb2 and galacto-trehalose models against Shiga toxins.
    Neri P; Nagano SI; Yokoyama S; Dohi H; Kobayashi K; Miura T; Inazu T; Sugiyama T; Nishida Y; Mori H
    Microbiol Immunol; 2007; 51(6):581-92. PubMed ID: 17579269
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Adaptive Radioresistance of Enterohemorrhagic Escherichia coli O157:H7 Results in Genomic Loss of Shiga Toxin-Encoding Prophages.
    Gaougaou G; Vincent AT; Krylova K; Habouria H; Bessaiah H; Baraketi A; Veyrier FJ; Dozois CM; Déziel E; Lacroix M
    Appl Environ Microbiol; 2023 Apr; 89(4):e0130622. PubMed ID: 37014232
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Characterization of enterohemorrhagic Escherichia coli from diarrhoeic patients with particular reference to production of Shiga-like toxin.
    Amin MA; Hashem HR; El-Mahallawy HS; Abdelrahman AA; Zaki HM; Azab MM
    Microb Pathog; 2022 May; 166():105538. PubMed ID: 35436562
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Anti-Shiga toxin 2 antibodies in enterohemorrhagic Escherichia coli O104:H4 infected patients may predict hemolytic uremic syndrome.
    Dammermann W; Mihajlov V; Middendorf B; Mellmann A; Karch H; Lüth S; Ullrich S
    J Gastroenterol Hepatol; 2018 Jul; 33(7):1353-1356. PubMed ID: 29280264
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Virulence genes of Shiga toxin-producing Escherichia coli isolated from food, animals and humans.
    Meng J; Zhao S; Doyle MP
    Int J Food Microbiol; 1998 Dec; 45(3):229-35. PubMed ID: 9927001
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Enterohemorrhagic Escherichia coli and hemolytic-uremic syndrome].
    Allerberger F; Sölder B; Caprioli A; Karch H
    Wien Klin Wochenschr; 1997 Sep; 109(17):669-77. PubMed ID: 9381722
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Whole-Genome Sequencing Analysis of a
    Kim TY; La TM; Kim T; Yun SA; Lee SW; Huh HJ; Lee NY
    Diagnostics (Basel); 2021 Oct; 11(10):. PubMed ID: 34679522
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The Effects of Shiga Toxin 1, 2 and Their Subunits on Cytokine and Chemokine Expression by Human Macrophage-Like THP-1 Cells.
    Brandelli JR; Griener TP; Laing A; Mulvey G; Armstrong GD
    Toxins (Basel); 2015 Oct; 7(10):4054-66. PubMed ID: 26473922
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Shiga/verocytotoxins and Shiga/verotoxigenic Escherichia coli in animals.
    Mainil J
    Vet Res; 1999; 30(2-3):235-57. PubMed ID: 10367357
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Enterohemorrhagic E. coli alters murine intestinal epithelial tight junction protein expression and barrier function in a Shiga toxin independent manner.
    Roxas JL; Koutsouris A; Bellmeyer A; Tesfay S; Royan S; Falzari K; Harris A; Cheng H; Rhee KJ; Hecht G
    Lab Invest; 2010 Aug; 90(8):1152-68. PubMed ID: 20479715
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Detection of Shiga toxin (Stx)-producing Escherichia coli (STEC) in bovine dairy herds in Northern Italy.
    Trevisani M; Mancusi R; Delle Donne G; Bacci C; Bassi L; Bonardi S
    Int J Food Microbiol; 2014 Aug; 184():45-9. PubMed ID: 24495690
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Verotoxin Receptor-Based Pathology and Therapies.
    Lingwood C
    Front Cell Infect Microbiol; 2020; 10():123. PubMed ID: 32296648
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Probiotic Lactobacillus reuteri ameliorates disease due to enterohemorrhagic Escherichia coli in germfree mice.
    Eaton KA; Honkala A; Auchtung TA; Britton RA
    Infect Immun; 2011 Jan; 79(1):185-91. PubMed ID: 20974822
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Advances in the development of enterohemorrhagic Escherichia coli vaccines using murine models of infection.
    Garcia-Angulo VA; Kalita A; Torres AG
    Vaccine; 2013 Jul; 31(32):3229-35. PubMed ID: 23707170
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Intestinal mucus-derived metabolites modulate virulence of a clade 8 enterohemorrhagic
    Garimano N; Scalise ML; Gómez F; Amaral MM; Ibarra C
    Front Cell Infect Microbiol; 2022; 12():975173. PubMed ID: 36004327
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prevention of enteric bacterial infections and modulation of gut microbiota with conjugated linoleic acids producing
    Peng M; Tabashsum Z; Patel P; Bernhardt C; Biswas C; Meng J; Biswas D
    Gut Microbes; 2020 May; 11(3):433-452. PubMed ID: 31411526
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Enterohemorrhagic Escherichia coli Hybrid Pathotype O80:H2 as a New Therapeutic Challenge.
    Soysal N; Mariani-Kurkdjian P; Smail Y; Liguori S; Gouali M; Loukiadis E; Fach P; Bruyand M; Blanco J; Bidet P; Bonacorsi S
    Emerg Infect Dis; 2016 Sep; 22(9):1604-12. PubMed ID: 27533474
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Genes involved in the virulence of enterohemorrhagic Escherichia coli].
    Izumiya H; Watanabe H
    Nihon Rinsho; 1997 Mar; 55(3):641-5. PubMed ID: 9086773
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.